Law360 (August 17, 2021, 7:45 PM EDT) — Canadian cannabis giant Tilray and U.S. cannabis retailer MedMen announced Tuesday that they had entered into what company principals described as a “game-changing” transaction that could pave the way for Tilray to dominate the U.S. marijuana market pending federal legalization.
Toronto-based Tilray Inc., along with other investors, will acquire an approximately $165.8 million chunk of MedMen Enterprises Inc.’s outstanding notes and warrants currently held by private equity fund Gotham Green Partners LLC and other funds, with an eye toward converting them into equity in MedMen if and when the U.S. legalizes pot.
Nine U.S. and Canadian law firms, including Weil Gotshal,…
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!